We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Genetic Hypercoagulability Syndromes: Does Testing Really Matter?

Michel Procopiou, MD
Arch Intern Med. 2002;162(15):1784-1785. doi:.
Text Size: A A A
Published online


I read with interest the recent review by Dr Thomas about hypercoagulability syndromes.1 I would like to comment on the author's recommendations regarding genetic testing and on his suggested approach to treatment of hypercoagulability.

What is the value of genetic testing for the individual presenting with venous thromboembolism? Dr Thomas (and many other experts2,3) states that recurrent idiopathic thrombosis, young age, and a family history of thrombosis are indications for genetic testing. Patients with recurrent idiopathic thrombosis are at high risk of a new episode because the prior thromboses prove that they have a strong thrombotic tendency.4 The sixth American College of Chest Physicians (2000) guidelines for antithrombotic therapy recommend prolonged anticoagulation for such patients whether genetic test results are positive or negative.4 In other words, if the pretest probability of a recurrent event is very high in these patients, a negative genetic test result will not reduce significantly the posttest probability, whereas a positive test result will only confirm that the patient has hypercoagulability.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles